TRITON-X is most effective among three decellularization agents for ACL tissue engineering
✍ Scribed by Patrick Vavken; Shilpa Joshi; Martha M. Murray
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 230 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0736-0266
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Ruptures of the anterior cruciate ligament (ACL) are still associated with high rates of long‐term complications, even in patients undergoing modern, state‐of‐the‐art replacement. Tissue‐engineering approaches have been shown to be of value in improving treatment of ACL ruptures. However, the success of tissue‐engineering procedures depends on the choice of an appropriate biomaterial. Decellularized ACL tissue potentially combines the structural composition of the targeted tissue with a reduced risk of graft rejection or disease transmission. In this study, we tested the effectiveness of currently available decellularization methods based on TRITON‐X, sodium dodecyl sulfate (SDS), and trypsin. After identifying the most effective decellularization method, the capacity for reseeding with ACL fibroblasts was studied. All decellularization protocols reduced DNA content, with TRITON‐X treatment having the greatest effect. Concurrently, decellularization did not affect tissue collagen or total protein content, but did decrease glycosaminoglycan content. TRITON‐X also resulted the least glycosaminoglycan depletion. Porcine ACL tissue after decellularization with TRITON‐X could be successfully reseeded with human ACL fibroblasts as demonstrated by steady DNA content and increasing pro‐collagen expression. © 2009 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 27:1612–1618, 2009